ALAMAR BIOSCIENCES, INC.

Alamar Biosciences, Inc. specializes in the development and deployment of advanced diagnostic systems for clinical and research applications, with deep expertise in next-generation sequencing platforms, in vitro diagnostic reagents, and analytical laboratory instrumentation. The company designs and manufactures proprietary NULISASEQ-based panels for neurological and inflammatory disease detection, delivering end-to-end solutions that integrate instrument hardware, assay chemistry, and laboratory testing services. Their technical capabilities span absolute quantification of biomarkers in plasma samples, multiplexed nucleic acid analysis, and validated workflows for CNS disease profiling, positioning them as a niche provider of precision diagnostics for complex biological targets. A key differentiator is their vertically integrated approach—combining instrument manufacturing with assay development and clinical testing services—enabling rapid translation of research tools into validated diagnostic products. The contractor maintains a consistent and exclusive relationship with the Department of Health and Human Services, delivering a broad spectrum of laboratory and diagnostic services across medical testing, in vitro diagnostics, and analytical instrumentation. All recent awards stem from HHS programs, indicating a trusted partnership focused on advancing molecular diagnostics for public health initiatives, particularly in neurology and immunology. Alamar’s primary industry focus lies in analytical laboratory instrument manufacturing, in vitro diagnostic substance manufacturing, and testing laboratory services, reflecting a specialized niche in molecular diagnostics. They serve the biomedical research and clinical diagnostics markets with highly targeted assays and integrated platforms, differentiating themselves through proprietary sequencing technologies and closed-system workflows. As a small business structured as a 2L entity based in Fremont, California, Alamar Biosciences operates without federal certifications but maintains a focused government market presence through direct HHS engagements. Their geographic positioning in the Bay Area supports access to biotech talent and R&D infrastructure critical to their innovation-driven model.